Mo-Rez shows strong early responses in ovarian, endometrial cancers Rare Cancer News
Mo-Rez shows strong early responses in gynecologic cancers Rare Cancer News
S’pore-led studies make breakthroughs in treating cancers in women The Straits Times
S’pore-led studies make breakthroughs in treating challenging cancers in women The Straits Times
MicroRNAs (miRNAs), a category of small (18-25 nucleotides) non-coding transcripts that modulate gene expression at the post-transcriptional level, are necessary for regulatory processes in female reproduction, specifically in ovarian function …
GSK’s Phase I ADC trial succeeds in treating advanced gynecological cancers BioXconomy
A Chemo-Free Option for Some Advanced Endometrial Cancers? Medscape
Endocrine-disrupting chemicals (EDCs) are a global concern for human health and the environment. EDCs include plasticizers, pharmaceutical agents, industrial chemicals, fungicides, and pesticides. Thus, EDC exposure is a manmade consequence …
Annexin A2 (ANXA2) is a calcium-dependent protein with high affinity for phospholipids, and its multifunctional nature has drawn increasing attention in the onset and progression of various disorders of the …
Background/Objective: RNA modifications, including N6-methyladenosine (m6A), 5-methylcytosine (m5C), 7-methylguanosine (m7G), N1-methyladenosine (m1A), pseudouridine (Ψ), N4-acetylcytidine (ac4C), 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) and adenosine-to-inosine (A-to-I) editing, constitute a critical layer of post-transcriptional regulation that …